N-Iodosuccinimide (CAS 516-12-1) User Guide
Table of Contents
1. Product Information & Specifications
| Parameter | N-Iodosuccinimide (CAS 516-12-1) | Competitor A | Competitor B |
|---|---|---|---|
| Purity | ≥99% | ≥97% | ≥95% |
| Appearance | White to off-white crystalline powder | Yellowish powder | Off-white granules |
| Solubility | Soluble in DMF, DMSO, THF | Partial solubility in DMF | Limited solubility |
| Iodine Content | 44-46% | 42-44% | 40-43% |
2. Key Applications
- Organic Synthesis: Selective iodination agent for alkenes, alkynes, and aromatic compounds
- Pharmaceutical Intermediates: Critical in synthesizing anti-thyroid drugs and radiocontrast agents
- Polymer Chemistry: Modifies polymer chains for UV-resistant materials
- Research Reagent: Used in radical-initiated reactions and heterocycle formation
3. Usage Cases
Case 1: Iodination of Steroidal Compounds
Procedure: Dissolve 1.2 eq N-iodosuccinimide in anhydrous DCM under nitrogen. Add 1 eq substrate dropwise at 0°C. Monitor reaction via TLC (Hexane:EA = 3:1). Yield: 82-89%.
Case 2: Synthesis of Aryl Iodides
Optimized Conditions: 1.5 eq NIS, BF3·Et2O catalyst in acetonitrile at 60°C for 6 hrs. Achieved 94% regioselectivity.
4. Client Success Stories
Client 1: Top 10 Pharma Company (Germany)
- Challenge: Required high-purity iodinated intermediates for Phase III clinical trials
- Solution: Customized particle size distribution (50-100 μm)
- Outcome: Reduced purification steps by 40%, accelerated FDA submission
Client 2: Specialty Chemical Manufacturer (USA)
- Challenge: Batch inconsistency in iodination reactions
- Solution: Technical grade NIS with stabilized succinimide content
- Outcome: Achieved 99.2% batch-to-batch reproducibility
5. Request a Quote
Contact our technical team for bulk pricing, COA, or custom synthesis requirements:
- Email: info@vivalr.com
- Tel: (86) 15866781826
Next Steps:
- Share your target compound structure
- Receive customized iodination protocol within 24hrs
- Request free 5g sample for method validation



评论
目前还没有评论。